|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Zogenix Inc [ZGNX]
$37.39 0.31 (0.82%)
Market Cap 1.59 Billion
Zogenix Inc is engaged in developing and commercializing therapeutic solutions for people living with serious and life-threatening rare CNS disorders and medical conditions. Its product candidate includes ZX008, low-dose fenfluramine for the treatment of Dravet syndrome, LGS, and potentially other rare and catastrophic epilepsy disorders.
EPS -0.83 P/E Ratio 0.00
Previous Earnings Thu, Feb 28, 2019
Pay Date --
This list of trending stocks may change throughout the trading day.